Similar Items: Response Letter to ‘Letter to the Editor Regarding Complementary Strategy of Maternal Immunization and Monoclonal Antibodies for the Prevention of Respiratory Syncytial Virus Among Italian Infants: A Cost-Effectiveness Assessment’
- Letter to the Editor Regarding “Complementary Strategy of Maternal Immunization and Monoclonal Antibodies for the Prevention of Respiratory Syncytial Virus Among Italian Infants: A Cost-Effectiveness Assessment”
- Budget Impact of Strategies Involving RSVpreF and Nirsevimab to Protect Infants in Saudi Arabia Against Respiratory Syncytial Virus
- Analysis of the Economic and Public Health Impact of New Immunization Strategies in Infants Against Respiratory Syncytial Virus (RSV) in Colombia
- An Introduction to Competing Risks in Epidemiology [Letter]
- Response to the Letter by Guagliardo et al.
- An Introduction to Competing Risks in Epidemiology [Response to Letter]